BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33548030)

  • 1. Implications of liver injury in risk-stratification and management of patients with COVID-19.
    Shao J; Liang Y; Li Y; Ding R; Zhu M; You W; Wang Z; Huang B; Wu M; Zhang T; Li K; Wu W; Wu L; Wang Q; Xia X; Wang S; Lu L
    Hepatol Int; 2021 Feb; 15(1):202-212. PubMed ID: 33548030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China.
    Zhang SS; Dong L; Wang GM; Tian Y; Ye XF; Zhao Y; Liu ZY; Zhai JY; Zhao ZL; Wang JH; Zhang HM; Li XL; Wu CX; Yang CT; Yang LJ; Du HX; Wang H; Ge QG; Xiu DR; Shen N
    World J Gastroenterol; 2021 Mar; 27(9):835-853. PubMed ID: 33727773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
    Turgutalp K; Ozturk S; Arici M; Eren N; Gorgulu N; Islam M; Uzun S; Sakaci T; Aydin Z; Sengul E; Demirelli B; Ayar Y; Altiparmak MR; Sipahi S; Mentes IB; Ozler TE; Oguz EG; Huddam B; Hur E; Kazancioglu R; Gungor O; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    BMC Nephrol; 2021 Jan; 22(1):29. PubMed ID: 33446135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization.
    Suh HJ; Lee E; Park SW
    J Korean Med Sci; 2021 May; 36(19):e139. PubMed ID: 34002553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of cardiac markers in risk-stratification and management for COVID-19 patients.
    Li P; Wu W; Zhang T; Wang Z; Li J; Zhu M; Liang Y; You W; Li K; Ding R; Huang B; Wu L; Duan W; Han Y; Li X; Tang X; Wang X; Shen H; Wang Q; Yan H; Xia X; Ji Y; Chen H
    Crit Care; 2021 Apr; 25(1):158. PubMed ID: 33902676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality.
    Paek JH; Kim Y; Park WY; Jin K; Hyun M; Lee JY; Kim HA; Kwon YS; Park JS; Han S
    PLoS One; 2020; 15(12):e0243528. PubMed ID: 33296419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients.
    Jimenez-Solem E; Petersen TS; Hansen C; Hansen C; Lioma C; Igel C; Boomsma W; Krause O; Lorenzen S; Selvan R; Petersen J; Nyeland ME; Ankarfeldt MZ; Virenfeldt GM; Winther-Jensen M; Linneberg A; Ghazi MM; Detlefsen N; Lauritzen AD; Smith AG; de Bruijne M; Ibragimov B; Petersen J; Lillholm M; Middleton J; Mogensen SH; Thorsen-Meyer HC; Perner A; Helleberg M; Kaas-Hansen BS; Bonde M; Bonde A; Pai A; Nielsen M; Sillesen M
    Sci Rep; 2021 Feb; 11(1):3246. PubMed ID: 33547335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.
    Campos-Murguía A; Román-Calleja BM; Toledo-Coronado IV; González-Regueiro JA; Solís-Ortega AA; Kúsulas-Delint D; Cruz-Contreras M; Cruz-Yedra N; Cubero FJ; Nevzorova YA; Martínez-Cabrera CF; Moreno-Guillén P; Lozano-Cruz OA; Chapa-Ibargüengoitia M; Gulías-Herrero A; Aguilar-Salinas CA; Ruiz-Margáin A; Macías-Rodríguez RU
    Dig Liver Dis; 2021 May; 53(5):525-533. PubMed ID: 33551355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China.
    Lei C; Lin W; Deng X; Hu F; Chen F; Cai W; Li Y; Wen C; Guan Y; Wang J; Chen X; Cao Y; Li F; Tang X; Li L
    J Clin Virol; 2020 Dec; 133():104661. PubMed ID: 33096290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.
    Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y
    Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems.
    Kodama T; Obinata H; Mori H; Murakami W; Suyama Y; Sasaki H; Kouzaki Y; Kawano S; Kawana A; Mimura S
    J Infect Chemother; 2021 Feb; 27(2):336-341. PubMed ID: 33402303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.
    Pijls BG; Jolani S; Atherley A; Derckx RT; Dijkstra JIR; Franssen GHL; Hendriks S; Richters A; Venemans-Jellema A; Zalpuri S; Zeegers MP
    BMJ Open; 2021 Jan; 11(1):e044640. PubMed ID: 33431495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.
    Banno A; Hifumi T; Okamoto H; Masaki M; Seki K; Isokawa S; Otani N; Hayashi K; Ishimatsu S
    BMC Infect Dis; 2021 Feb; 21(1):163. PubMed ID: 33563218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.